Societal CDMO

Activities: Manufacturing

Trending Articles

  1. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  2. Fasenra for EGPA: addressing unmet needs Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  5. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Manufacturing

Societal CDMO expands manufacturing to address expanding psychedelic market

Societal CDMO has announced an expansion of its controlled substance manufacturing capabilities to address expanding psychedelic drug development market
Manufacturing

Societal CDMO wins tech transfer and production contract for HIV drug candidate

The small molecule CDMO has been selected to provide services to support the ongoing clinical development of a novel drug candidate in Europe
Manufacturing

Societal CDMO unveils new "20/80" tech transfer service model

The pharmaceutical CDMO has developed a service model to provide time- and cost-efficient preparedness strategy for mitigating supply chain risks and vulnerabilities
Subscribe now